A carregar...
Role of erlotinib in the management of pancreatic cancer
Pancreatic cancer is a largely chemo-resistant disease with a poor prognosis. Despite the adoption of gemcitabine monotherapy as a standard of care, outcomes remain poor. Until recently randomized phase III studies have not demonstrated superiority of various cytotoxic combinations or a number of th...
Na minha lista:
Main Authors: | , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2006
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1936363/ https://ncbi.nlm.nih.gov/pubmed/18360654 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|